공시 • Dec 24
Elevate Uranium Ltd (ASX:EL8) acquired Uranium Generation Pty. Ltd. from Core Lithium Ltd (ASX:CXO) for AUD 4.9 million. Elevate Uranium Ltd (ASX:EL8) acquired Uranium Generation Pty. Ltd. from Core Lithium Ltd (ASX:CXO) for AUD 4.9 million on December 23, 2025. Under the Acquisition Agreement, Elevate Uranium Ltd agreed to pay AUD 2.5 million in cash at completion, issue 8,923,738 ordinary shares and a Net Smelter Royalty of 1.0% on any metals or minerals produced from EL31449, which hosts Napperby Project area. Fifty percent of the Consideration Shares (4,461,869 shares) will be subject to a voluntary six-month escrow period.
Elevate Uranium Ltd (ASX:EL8) completed the acquisition of Uranium Generation Pty. Ltd. from Core Lithium Ltd (ASX:CXO) on December 23, 2025. 공시 • Nov 01
Elevate Uranium Ltd has completed a Follow-on Equity Offering in the amount of AUD 25 million. Elevate Uranium Ltd has completed a Follow-on Equity Offering in the amount of AUD 25 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 71,428,572
Price\Range: AUD 0.35
Discount Per Security: AUD 0.021
Transaction Features: Subsequent Direct Listing 공시 • Oct 31
Elevate Uranium Ltd has filed a Follow-on Equity Offering in the amount of AUD 25 million. Elevate Uranium Ltd has filed a Follow-on Equity Offering in the amount of AUD 25 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 71,428,572
Price\Range: AUD 0.35
Discount Per Security: AUD 0.021
Transaction Features: Subsequent Direct Listing 공시 • Oct 01
Elevate Uranium Ltd, Annual General Meeting, Nov 27, 2025 Elevate Uranium Ltd, Annual General Meeting, Nov 27, 2025. Location: cwa house, 1176 hay street, wa 6005, west perth Australia Recent Insider Transactions • Aug 19
Non-Executive Chairman recently bought AU$251k worth of stock On the 14th of August, Scott Perry bought around 990k shares on-market at roughly AU$0.25 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. This was Scott's only on-market trade for the last 12 months. Board Change • Aug 18
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Stephen Mann was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Feb 04
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Non-Executive Director Stephen Mann was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Dec 24
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Non-Executive Director Stephen Mann was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공시 • Dec 20
Elevate Uranium Ltd has completed a Follow-on Equity Offering in the amount of AUD 25.08 million. Elevate Uranium Ltd has completed a Follow-on Equity Offering in the amount of AUD 25.08 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 32,444,977
Price\Range: AUD 0.325
Discount Per Security: AUD 0.0195
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 44,724,255
Price\Range: AUD 0.325
Discount Per Security: AUD 0.0195
Transaction Features: Subsequent Direct Listing 공시 • Oct 23
Elevate Uranium Ltd has filed a Follow-on Equity Offering in the amount of AUD 25.08 million. Elevate Uranium Ltd has filed a Follow-on Equity Offering in the amount of AUD 25.08 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 32,444,977
Price\Range: AUD 0.325
Discount Per Security: AUD 0.0195
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 44,724,255
Price\Range: AUD 0.325
Discount Per Security: AUD 0.0195
Transaction Features: Subsequent Direct Listing New Risk • Sep 28
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$9.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$9.3m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (AU$476k revenue, or US$329k). Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (AU$120.3m market cap, or US$83.1m). New Risk • Sep 23
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (AU$100.2m market cap, or US$68.2m). 공시 • Sep 21
Elevate Uranium Ltd, Annual General Meeting, Nov 29, 2024 Elevate Uranium Ltd, Annual General Meeting, Nov 29, 2024. Location: at `the board room`, cwa house, 1176 hay street, west perth wa 6005 Australia Board Change • Aug 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Non-Executive Director Stephen Mann was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. New Risk • Jun 05
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$149.6m (US$99.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Shareholders have been diluted in the past year (12% increase in shares outstanding). Market cap is less than US$100m (AU$149.6m market cap, or US$99.4m). New Risk • Feb 23
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$145.0m (US$95.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 45% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Shareholders have been diluted in the past year (12% increase in shares outstanding). Market cap is less than US$100m (AU$145.0m market cap, or US$95.2m). New Risk • Nov 28
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 45% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Shareholders have been diluted in the past year (3.3% increase in shares outstanding). Market cap is less than US$100m (AU$138.0m market cap, or US$91.2m). 공시 • Sep 22
Elevate Uranium Ltd, Annual General Meeting, Nov 24, 2023 Elevate Uranium Ltd, Annual General Meeting, Nov 24, 2023, at 10:30 W. Australia Standard Time. Location: "The Presidents Room",The Celtic Club, 48 Ord Street West Perth WA 6005 West Perth Australia